LGMD2B

The International Dysferlinopathy Registry provides an opportunity for patients with dysferlinopathies to participate in research studies, clinical trials and to obtain the best possible care. The registry is open to all patients worldwide with identified mutations in the dysferlin gene.

The website provides information for potential participants, their doctors and research scientists. In addition, some of the website has been translated into German, Spanish, Catalan, Italian, French, and Japanese. Information leaflets are available in English, French, Spanish, German, Italian, Catalan and Japanese.